Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results matching your filters

The Fifth INTEnsive pReventing Secondary Injury in Acute Cerebral Haemorrhage Trial Within ACT-GLOBALRecruiting
NCT06763055Phase 3Updated Jul 8, 2026
Sponsor: The George Institute
Intracerebral Hemorrhage · Spontaneous Intracerebral Hemorrhage · Supratentorial Intracerebral Haemorrhage · Acute Intracerebral Haemorrhage
Australia, China
A Phase 2/3 Study of Brepocitinib in Adults With Lichen PlanopilarisRecruiting
NCT07532603Phase 2, Phase 3Updated Jul 8, 2026
Sponsor: Priovant Therapeutics, Inc.
Lichen Planopilaris
United States, Australia, Canada, United Kingdom
Artificial Intelligence Model-Guided Neoadjuvant Anti-HER2 Targeted TherapyRecruiting
NCT07528716Phase 3Updated Jul 8, 2026
Sponsor: Fudan University
Breast Cancer
China
A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE)Recruiting
NCT07647510Phase 3Updated Jul 8, 2026
Sponsor: Dianthus Therapeutics
Myasthenia Gravis, Generalized
United States
Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI PatientsRecruiting
NCT04031456Phase 2, Phase 3Updated Jul 8, 2026
Sponsor: Genesis Athens Clinic
Menopause, Premature · Menopause Related Conditions · Menopausal Syndrome · Premature Ovarian Failure
Greece
A Study of JNT-517 in Participants With Phenylketonuria (PKU)Recruiting
NCT06971731Phase 3Updated Jul 8, 2026
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Phenylketonuria
United States, Australia, Canada, Czechia, France +5 more
Evaluating the Response-Guided Therapy With Neoadjuvant Endocrine Therapy to Optimize Adjuvant Treatment in Premenopausal HR+/HER2- Breast Cancer (JCOG2402, Young HOPE)Recruiting
NCT07671885Phase 3Updated Jul 8, 2026
Sponsor: Tokyo Women's Medical University
Breast Cancer
Japan
A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCARecruiting
NCT07282353Phase 3Updated Jul 8, 2026
Sponsor: Cascade Pharmaceuticals, Inc
Primary Biliary Cholangitis
China
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).Recruiting
NCT06133972Phase 3Updated Jul 8, 2026
Sponsor: Novartis Pharmaceuticals
Systemic Lupus Erythematosus
United States, Argentina, Australia, Brazil, Bulgaria +24 more
Efficacy and Safety of CHF 5993 100/6/12.5 μg HFA-152a pMDI in Patients With Asthma Uncontrolled on Medium Doses of Inhaled Corticosteroids in Combination With Long-acting ß2-agonistsRecruiting
NCT07546981Phase 3Updated Jul 8, 2026
Sponsor: Chiesi Farmaceutici S.p.A.
Asthma
China
Autologous Platelet Rich Plasma Intraovarian Infusion for Poor RespondersRecruiting
NCT05181748Phase 2, Phase 3Updated Jul 8, 2026
Sponsor: Genesis Athens Clinic
Poor Response to Ovulation Induction · Infertility, Female · Ovarian Insufficiency · Ovarian Failure
Greece
SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate AdenocarcinomaRecruiting
NCT06205316Phase 3Updated Jul 8, 2026
Sponsor: Mayo Clinic
Biochemically Recurrent Prostate Carcinoma · Oligometastatic Prostate Carcinoma · Recurrent Prostate Adenocarcinoma · Stage IIB Prostate Cancer AJCC v8
United States
A Study to Evaluate the SYH2053 Injection in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)Recruiting
NCT07465263Phase 3Updated Jul 8, 2026
Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Heterozygous Familial Hypercholesterolemia (HeFH)
China
A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line TreatmentRecruiting
NCT07518147Phase 3Updated Jul 8, 2026
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Gastric Cancer · Gastroesophageal Junction Adenocarcinoma
China
A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating PolyradiculoneuropathyRecruiting
NCT07540221Phase 3Updated Jul 8, 2026
Sponsor: Grifols Therapeutics LLC
CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy)
United States
A Trial of TAK-861 for the Treatment of Narcolepsy With CataplexyRecruiting
NCT07363720Phase 3Updated Jul 8, 2026
Sponsor: Takeda
Narcolepsy Type 1 (NT1) · Narcolepsy With Cataplexy
United States, France, Germany, Italy, Netherlands +2 more
A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of AgeRecruiting
NCT07406360Phase 3Updated Jul 8, 2026
Sponsor: GlaxoSmithKline
Measles · Measles-Mumps-Rubella+Chickenpox Vaccine
United States
Preventive Effect of Clopidogrel on the Systemic Sclerosis Development RiskRecruiting
NCT05098704Phase 2, Phase 3Updated Jul 7, 2026
Sponsor: University Hospital, Bordeaux
Scleroderma · Systemic Sclerosis
France
Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical StormRecruiting
NCT06281977Phase 3Updated Jul 7, 2026
Sponsor: Ottawa Heart Institute Research Corporation
Ventricular Tachycardia · Ventricular Arrhythmias · Ventricular Fibrillation · Recurrent Ventricular Tachycardia
United States, Canada
Phase III Clinical Study of VC005 in Adult and Adolescents With Mild to Moderate Atopic DermatitisRecruiting
NCT07592585Phase 3Updated Jul 7, 2026
Sponsor: Jiangsu vcare pharmaceutical technology co., LTD
Atopic Dermatitis
China
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic DermatitisRecruiting
NCT06311682Phase 3Updated Jul 7, 2026
Sponsor: LEO Pharma
Atopic Dermatitis
United States, Belgium, Canada, Croatia, Germany +8 more
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).Recruiting
NCT07602582Phase 3Updated Jul 7, 2026
Sponsor: Eli Lilly and Company
Alzheimer Disease · Dementia · Plaque, Amyloid
United States, Japan, Puerto Rico
MDT-0123 Japan StudyRecruiting
NCT07414745Phase 3Updated Jul 7, 2026
Sponsor: Medtronic Spinal and Biologics
Disc Degeneration · Spinal Deformity
Japan
A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent Epithelial Ovarian Cancer(PANKU-GYN01)Recruiting
NCT06994195Phase 3Updated Jul 7, 2026
Sponsor: Sichuan Baili Pharmaceutical Co., Ltd.
Epithelial Ovarian Cancer · Fallopian Tube Cancer · Primary Peritoneal Cancer
China
Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUreRecruiting
NCT07687186Phase 3Updated Jul 7, 2026
Sponsor: Tasly Pharmaceutical Group Co., Ltd
Heart Failure
China

Previous page Next page